AXONNASDAQ— Axon Enterprise Inc. Price & Analysis

Axon Enterprise Inc.

INDUSTRIALS — AEROSPACE & DEFENSE

$515.67

-$22.48-4.18%

Market Cap: $41.19B; Large Cap
P/E Ratio: 217.59; Fwd: 65.79
EPS (TTM): $2.33
Div. Yield: N/A

Technical Summary

RSI (14)40.73Neutral

SMA (50)$566.83Bearish

SMA (200)$505.56Bullish

MACD-8.2423Bearish

Bollinger$512.66 – $672.20Mid

Stochastic13.94Oversold

Theo Outlook

Axon Enterprise trades at a premium valuation with a trailing P/E of 213.09 and market capitalization of $41.89 billion, supported by robust revenue growth of 35.3% year-over-year to $3.22 billion TTM and EPS of $2.42. The forward P/E of 68.49 reflects strong growth expectations despite a recent quarterly earnings contraction of 18.2%. Analysts maintain a consensus target of $693.40 with 18 buy/strong-buy ratings, positioning the stock as a high-growth play in the aerospace and defense sector. Key catalysts include continued expansion of TASER conducted energy weapons and software platforms, evidenced by 35.3% quarterly revenue growth and analyst coverage showing 8 strong-buy ratings. Earnings momentum is bolstered by international market penetration and recurring revenue from Axon Evidence and cloud services, with the latest quarter ending June 2026 demonstrating sustained top-line acceleration. Institutional ownership at 91.3% and insider holdings of 4.5% further signal confidence in product launches and market share gains. Risks center on the elevated valuation (P/E 213) vulnerable to macro headwinds such as defense budget cuts or regulatory scrutiny on conducted energy devices, compounded by a beta of 1.40 indicating higher volatility. Mitigation comes from diversified revenue streams, a strong balance sheet implied by book value of $45.23, and analyst target implying 22% upside from recent levels near the 50-day moving average of $566.83. Competitive pressures from legacy law-enforcement suppliers are offset by Axon's technological moat in digital evidence management. Analysis generated by HeyTheo AI based on SEC filings, earnings transcripts, and market data.

Analysis generated by HeyTheo AI on Sep 7, 2026.

Company Overview

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy weapons (DEC) under the TASER brand name in the United States and internationally. The company is headquartered in Scottsdale, Arizona.

Fundamental Snapshot

Revenue: $3.22B
EBITDA: $165.11M
Gross Profit: $1.92B
Operating Margin: 5.2%
Profit Margin: 6.2%
ROE: 6.2%
Book Value: $45.23
Beta: 1.4
52-Wk High: $792.16
52-Wk Low: $339.01
Avg Volume: 634.09K
PEG Ratio: 2.38

Frequently Asked Questions

What is Axon Enterprise's business model?

Axon Enterprise develops and sells conducted energy weapons under the TASER brand along with digital evidence management software and cloud services. The company generates recurring revenue through subscriptions to Axon Evidence and related platforms, with TTM revenue of $3.22 billion and EPS of $2.42.

What are Axon's primary revenue sources?

Primary revenue comes from TASER device sales, software subscriptions, and evidence management services. TTM revenue reached $3.22 billion with 35.3% year-over-year quarterly growth, while gross profit stood at $1.92 billion.

What competitive advantages does Axon hold?

Axon benefits from a strong technological moat in conducted energy weapons and integrated digital evidence platforms, supported by 91.3% institutional ownership and a book value of $45.23 per share. Its ecosystem creates high switching costs for law enforcement customers.

What are the key risks for AXON stock?

Key risks include the high trailing P/E of 213.09, recent 18.2% quarterly earnings decline, and regulatory scrutiny on TASER products. A beta of 1.40 adds volatility, though a $693.40 analyst target provides a buffer against macro defense spending cuts.

What is the growth outlook for Axon Enterprise?

Growth outlook remains positive with 35.3% revenue expansion and 18 buy/strong-buy analyst ratings targeting $693.40. Forward P/E of 68.49 and international expansion support continued momentum despite the latest quarter ending June 2026 showing mixed earnings.